Medicine
fromNature
20 hours agoAntibodies and T cells join forces for sustained HIV remission
T cells with stem-cell-like properties combined with antibody therapies could enable durable HIV control without continuous antiretroviral therapy.
Researchers gave 10 people with HIV a complex regimen of experimental immunotherapies, then discontinued the daily pills that kept the virus at bay. In six participants, the virus rebounded slowly and stayed at a low level for months, and one person's immune system kept the virus in check for more than a year and a half - giving scientists hope that they could optimize the approach to create a cure.